Mainz Biomed Considers Reverse Stock Split for Nasdaq Compliance

TipRanksNov 16 06:40

The Oncology Bet Is Already Paying Off For Pfizer

BenzingaNov 14 08:23

Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets

GlobeNewswireNov 12 22:00

Mainz Biomed Highlights Growth and Innovations for 2025

TipRanksOct 21 20:50

Mainz Biomed Reported Revenue Of $0.52M For H1 2024, Up By 4% YoY, EPS Loss Of $(0.49)

BenzingaOct 21 20:06

Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update

GlobeNewswireOct 21 20:01